NSE filing, NSE: QLINE. Summary written from the filing by ALFA Finder's alert engine.
Q-Line Biotech Ltd: key numbers
- Share price
- ₹525.05
- Market cap
- ₹1,225 Cr
- Revenue (annual)
- ₹341.7 Cr
- Net profit (annual)
- ₹55.72 Cr
- P/E (TTM)
- 22.0×Sector 52.3×
- Promoter holding
- 67.51%
- FII holding
- 0.87%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Q-Line Biotech Ltd
All →Q-Line Biotech Annual General Meeting
Q-Line Biotech Limited held its 16th Annual General Meeting on September 30, 2026. The meeting transacted ordinary and special business, including financial statement adoption and director re-appointments.
Q-Line Biotech Annual General Meeting
Q-Line Biotech has sent a letter to shareholders with bounced emails, providing links to the Annual Report and 16th AGM Notice, scheduled for September 30, 2026.
Q-Line Biotech Annual Report
Q-Line Biotech Limited has submitted its Annual Report for the financial year 2025-26. The full document is accessible via the provided company website link.
Q-Line Biotech Other Announcement
Q-Line Biotech Limited has re-appointed M/s. P S P & Associates as Cost Auditors for a 12-month term.
- Execution
- 12 months
Q-Line Biotech Partnership
Q-Line Biotech amended its license agreement with Boule Medical AB, Sweden. The revision includes a 25% reduction in license/royalty costs effective from July 2026.
- From
- Boule Medical AB
- Execution
- 5 years
Q-Line Biotech Other Announcement
Q-Line Biotech Limited filed its quarterly Reconciliation of Share Capital Audit Report, as required under SEBI Regulation 76, for the quarter ended June 30, 2026.
Other board meeting outcome announcements
All →Hardcastle & Waud Manufacturing Company Board Meeting Outcome
The board revoked its earlier Mumbai office shift and approved moving the registered office to Mira Road, Thane. The change awaits shareholder and regulatory approval.
Greenply Industries Board Meeting Outcome
Greenply appoints MSKA & Associates LLP as statutory auditor for five years from the 2027 AGM, subject to shareholder approval. Incumbent BSR & Co. continues until then.
- Execution
- 5 years, from the conclusion of the 37th AGM (2027) to the conclusion of the 42nd AGM (2032)
Greaves Cotton Board Meeting Outcome
Greaves Cotton confirmed its Board met on October 29, 2026, on unaudited half-year results. No new financial figures are disclosed in this filing.
Popular Vehicles and Services Board Meeting Outcome
Popular Vehicles passed a circular resolution approving a routine AOA amendment on the common seal. A postal ballot notice and scrutinizer were also appointed.
R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.